Global Health Solutions(TTRX)

Search documents
美国 IPO 市场本周动态:多领域企业密集上市,SPAC与微型股成亮点
美股研究社· 2025-10-11 09:31
Core Insights - The U.S. IPO market remains active despite government shutdown, with 6 traditional IPOs and 2 SPACs launched this week, alongside 13 companies filing for initial public offerings [1][12]. Group 1: IPO Activity - Alliance Laundry Holdings (ALH) raised $826 million, pricing at the upper limit of its range, achieving a market cap of $4.5 billion, and saw a 14% stock price increase [1]. - Phoenix Education Partners (PXED) raised $136 million, pricing at the midpoint of its range, with a market cap of $1.3 billion and a 13% stock price increase [1]. - Ping An Good Doctor (POM) raised $20 million, pricing at the lower limit of its range, with a market cap of $474 million and a 9% stock price increase [2]. - One and One Green Tech (YDDL) raised $10 million, pricing at the midpoint of its range, achieving a market cap of $27 million and a significant 31% stock price increase [2]. - Leifras (LFS) raised $5 million, pricing at the lower limit of its range, with a market cap of $10.5 million, but experienced a 5% stock price decline [2]. - Turn Therapeutics (TTRX) debuted via direct listing at $10, but saw a 26% decline in stock price [3]. Group 2: SPAC Activity - Two SPACs completed their listings: GigCapital8 (GIWWU) raised $220 million and Lake Superior Acquisition (LKSPU) raised $100 million, focusing on energy, social media, and consumer goods [4]. - Five SPACs filed for IPOs, including Xsolla SPAC 1 (XSOLU.RC) and Alussa Energy Acquisition II (ALUBU), both aiming to raise $250 million [8][10]. Group 3: Upcoming IPOs and Market Trends - 13 companies filed for IPOs, including BillionToOne (BLLN), Evommune (EVMN), and Central Bancompany (CBC), each planning to raise $100 million [6]. - The SEC issued new guidelines allowing companies to announce pricing ranges and set final pricing above the range, which may encourage more companies to proceed with listings amid the government shutdown [12].
美股异动 | 次新股Turn Therapeutics(TTRX.US)涨超144% 致力于开发下一代皮肤病、伤口和抗感染疗法
Zhi Tong Cai Jing· 2025-10-09 16:08
智通财经APP获悉,周四,次新股Turn Therapeutics(TTRX.US)股价上涨,截至发稿,该股涨超144%, 报16.95美元。Turn Therapeutics致力于开发下一代皮肤病、伤口和抗感染疗法。该公司拥有一种专有的 递送平台技术 "PermaFusion®",该技术旨在让水溶性的活性成分在无需乳化剂的情况下,以油性载体 渗透进入皮肤、指甲或黏膜,从而增强可用性和减少刺激性。 ...
Turn Therapeutics Shares Skyrocket 134% After Hours Following Nasdaq Debut - Turn Therapeutics (NASDAQ:TTRX)
Benzinga· 2025-10-09 05:06
Turn Therapeutics Inc. (NASDAQ:TTRX) saw its shares soar by 134.29% after the market closed on Wednesday, closing at $16.40.Check out the current price of TTRX stock here. Nasdaq ListingThe clinical-stage biotechnology company commenced trading on the Nasdaq Capital Market on Wednesday.Nasdaq Exchange welcomed the company on social media, calling it a company “paving the way in pharmaceutical technologies that heal, not just manage.”The Securities and Exchange Commission (SEC) declared Turn’s registration s ...
After-Hours Surge: Turn Therapeutics Rockets 134% Post-Close On Nasdaq Debut; Biotech Stocks Rally
RTTNews· 2025-10-09 04:03
Core Insights - U.S.-listed biotech and healthcare stocks experienced significant bullish activity in after-hours trading, with Turn Therapeutics Inc. leading the surge with a 134.29% increase to $16.40 following its Nasdaq debut [1] Group 1: Company Performances - Talphera Inc. reached a new 52-week high in regular trading and added 4.55% after hours to close at $1.38, driven by momentum despite no new updates [2] - Personalis Inc. rose 1.50% to $8.81 in after-hours trading, having hit a 52-week high earlier in the day, likely due to ongoing investor interest in precision oncology [2] - Ionis Pharmaceuticals Inc. climbed 3.64% to $72.51 after hours, supported by its Innovation Day presentation and reaffirmation of its pipeline strategy, leading to a new 52-week high during regular trading [3] - Sensei Biotherapeutics Inc. increased 5.23% to $12.08, with anticipation building ahead of its pipeline updates scheduled for October 20 [3] - Corbus Pharmaceuticals Holdings Inc. gained 4.77% to $14.06, preparing for participation in the Piper Sandler Virtual Oncology Symposium on October 9 [4] - Longeveron Inc. advanced 5.71% to $0.9801, with expectations for insights into its regenerative medicine pipeline at the ROTH Healthcare Opportunities Conference [4] - Palisade Bio Inc. rose 5.00% to $2.10 in after-hours trading, buoyed by a recent $138 million public offering that strengthened its balance sheet ahead of Phase 2 trials [5] Group 2: Market Trends - The after-hours session showcased a mix of technical breakouts, event-driven anticipation, and momentum trading, indicating a fertile environment for volatility and investment opportunities in the biotech sector [6]
Turn Therapeutics to Commence Trading Today on Nasdaq
Globenewswire· 2025-10-08 12:00
Founder & CEO, Bradley Burnam, to Ring NASDAQ “Closing Bell” at 4:00 PM ETWESTLAKE VILLAGE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics (“Turn” or the “Company”), a clinical-stage biotechnology company developing next-generation dermatology, wound, and anti-infective therapies, announces that its common stock is scheduled to commence trading today, October 8, 2025, on the Nasdaq Capital Market under ticker symbol “TTRX.” The Company’s registration statement on Form S-1 was declared effectiv ...
Turn Therapeutics Announces Expected First Day of Trading on NASDAQ Global Market
Businesswire· 2025-09-29 14:02
"Company†), a clinical-stage biotechnology company developing dermatology, wound care, and anti- infective therapies, today announced that it expects its common stock will begin trading on the Nasdaq Global Market under the ticker symbol "TTRX†on October 8, 2025. Copies of the prospectus, when available, may be obtained from Turn Therapeutics, 250 N. Westlake Blvd., Westlake Village, CA 91362. About Turn Therapeutics Tu. WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics ("Turn†or the ...